Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Codon AG (CNWK) NPV

Sell:€1.24 Buy:€1.31 Change: €0.10 (3.19%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:€1.24
Buy:€1.31
Change: €0.10 (3.19%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:€1.24
Buy:€1.31
Change: €0.10 (3.19%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.

Contact details

Address:
Warthestrasse 21
TELTOW
14513
Germany
Telephone:
+49 (3328) 43460
Website:
www.codon.de/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CNWK
ISIN:
DE000A1K0227
Market cap:
€60.13 million
Shares in issue:
43.73 million
Sector:
Biotechnology
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Hans Bauerfeind
    Chairman of the Supervisory Board
  • Thommy Staehlin
    Vice Chairman of the Supervisory Board
  • Tilmann Bur
    Member of the Management Board for Marketing and Sales

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.